Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01630109 · ClinicalTrials.gov registry record · Phase 4
Study of Metoclopramide in Small Bowel Capsule Endoscopy
A Phase 4 study, sponsored by Ascension Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT01630109: Completed Phase 4 study, sponsored by Ascension Health.
NCT01630109 is a Phase 4 study that has completed, run by Ascension Health. The registered enrollment target is 5 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01630109, a Phase 4 study, has completed, sponsored by Ascension Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
Patients undergoing small bowel capsule endoscopy will be randomized into 3 study groups to either receive 5 mg of metoclopramide, 10 mg of metoclopramide, or a placebo 30 minutes prior to swallowing the Pill Cam. This is a randomized, double-blind, placebo-controlled design. The outcomes to be assessed are capsule study completion rates, gastric transit time, small bowel transit time, and the effect of diabetes on pill capsule completion rates. The purpose of the study is to assess if metoclopramide given prior to pill capsule endoscopy has any effect on pill capsule completion rate, gastric transit time, small bowel transit time, and pill capsule completion rates in diabetes.
Primary Outcome
This study is investigating whether there is a difference in pill capsule completion rates between a treatment group (metoclopramide) vs. placebo. It is also looking at differences in completion rates between two different doses of metoclopramide (5 mg vs. 10 mg).
Interventions
- DRUG Placebo
- DRUG Metoclopramide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2012-12 |
| Est. Completion | 2013-06 |
| Phase | Phase 4 |
What the finished NCT01630109 record still lists
NCT01630109 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01630109 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01630109 about?
NCT01630109 is a clinical study titled "Study of Metoclopramide in Small Bowel Capsule Endoscopy". Patients undergoing small bowel capsule endoscopy will be randomized into 3 study groups to either receive 5 mg of metoclopramide, 10 mg of metoclopramide, or a placebo 30 minutes prior to swallowing the Pill Cam. This is a randomized, double-blind, placebo-controlled design. The outcomes to be asse...
What is the current status of trial NCT01630109?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2012-12. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01630109?
The interventions under investigation include: Placebo (DRUG), Metoclopramide (DRUG).
Who is sponsoring clinical trial NCT01630109?
This trial is sponsored by Ascension Health, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01630109's enrollment target sits among peer trials
5 1989th of 2000 higher than 7 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia